XML 64 R46.htm IDEA: XBRL DOCUMENT v3.24.1
STOCK-BASED COMPENSATION (Tables)
12 Months Ended
Dec. 31, 2023
Share-Based Payment Arrangement [Abstract]  
SUMMARY OF STOCK OPTIONS OUTSTANDING

Activity in the various Plans during the years ended December 31, 2023 and 2022 is reflected in the following table:

 

Options  Number of
Shares
   Weighted
Average
Exercise Price
 
Outstanding at January 1, 2022   54,303   $47.40 
Granted   1,250    19.60 
Exercised        
Forfeited   (1,603)   (80.80)
Outstanding at December 31, 2022   53,950   $45.80 
Exercisable at December 31, 2022   53,950   $45.80 

 

Options  Number of
Shares
   Weighted
Average
Exercise Price
 
Outstanding at January 1, 2023   53,950   $45.80 
Granted        
Exercised        
Forfeited   (350)   (83.20)
Outstanding at December 31, 2023   53,600   $45.55 
Exercisable at December 31, 2023   53,600   $45.55 
SCHEDULE OF FAIR VALUE OF STOCK OPTIONS ASSUMPTION

The Company has utilized the following assumptions in its Black-Scholes option valuation model to calculate the estimated grant date fair value of the options during the years ended December 31, 2023 and 2022:

 

   2023   2022 
   Assumptions   Assumptions 
Volatility – range       111.67%
Risk-free rate       1.81%
Expected term       10.0 years 
Exercise price      $19.60 
SCHEDULE OF SHARES AUTHORIZED UNDER STOCK OPTION PLANS BY EXERCISE PRICE RANGE

The following table summarizes the range of exercise prices and weighted average remaining contractual life for outstanding and exercisable options under the Company’s option plans as of December 31, 2023:

 

    Outstanding options   Exercisable options 
Exercise price
range
   Number of
options
   Weighted
average
remaining
contractual life
   Number of
options
   Weighted average
remaining
contractual life
 
                  
$ 0.01 to $49.99    37,000    6.6 years    37,000     6.6 years 
$50.00 to $69.99    15,100    4.5 years    15,100     4.5 years 
$70.00 to $89.99    1,500    2.4 years    1,500     2.4 years 
                       
      53,600    5.9 years    53,600     5.9 years 

SUMMARY OF RESTRICTED STOCK ACTIVITY

A summary of all restricted stock activity under the equity compensation plans for the years ended December 31, 2023 and 2022 is as follows:

 

   Number of
Restricted
shares
   Weighted
average
grant date
fair value
 
Nonvested balance, January 1, 2022   52,869   $37.40 
Granted   60,750    14.67 
Vested   (31,244)   (34.73)
Forfeited   (3,250)   (21.20)
Nonvested balance, December 31, 2022   79,125   $21.73 

 

   Number of
Restricted
shares
   Weighted
average
grant date
fair value
 
Nonvested balance, January 1, 2023   79,125   $21.73 
Granted   35,000    5.00 
Vested   (56,625)   (21.29)
Forfeited   (3,625)   (22.41)
Nonvested balance, December 31, 2023   53,875   $11.27 
SCHEDULE OF NON-VESTED BALANCE OF RESTRICTED STOCK

The nonvested balance of restricted stock vests as follows:

 

Years ended  Number of
shares
 
     
2024   27,750 
2025   19,000 
2026   4,125 
2027   2,000 
2028   1,000